The emerging gold-standard Spectro-Fluor™ biotechnology: A step forward fluorescence-free and radioisotope-free innovation

Journal of Bioengineering & Biomedical Science

ISSN: 2155-9538

Open Access

The emerging gold-standard Spectro-Fluor™ biotechnology: A step forward fluorescence-free and radioisotope-free innovation

International Conference on Significant Advances in Biomedical Engineering

April 27-29, 2015 Philadelphia, USA

Farid Menaa

Posters-Accepted Abstracts: J Bioengineer & Biomedical

Abstract :

Spectro-Fluor? also known as Carbon-Fluorine Spectroscopy (CFS?) or Fluoro-Raman Spectroscopy (FRS?) is a relatively new patented platform technology using a family of various methods and cost-effective devices called PLIRFA? (Pulsed Laser Isochronic Raman and Fluorescence Apparatus). Recently, a number of medical, pharmaceutical and nanotechnological applications have been developed using Spectro-Fluor?. The key feature of this progressive, non-destructive, non invasive and green technology is based on the discovery of a characteristic optical signature of carbon-fluorine bond(s) in the fingerprint spectral area of 500-900 cm-1 allowing rapid, ultra-specific and sensitive detection, characterization, imaging, and measurement of any fluoroorganics and fluoro-materials including F-polymers. Interestingly, since C-F bond is unique in its character it can be used as a molecular label. Furthermore, the C-F label is efficient, soluble, cheaper, smaller, more stable and less toxic than fluorescent dyes, nanoparticles or quantum dot materials. Thereby, C-F bonds are often incorporated into pharmaceutical, agrochemical and biological molecules in addition to polymers and nano-materials to achieve special properties (e.g. molecular stability, molecular tracing).

Biography :

Farid Menaa completed his PhD at 28 years from University of Jussieu/Sorbonne and Ministry of Defense (CEA/CEN), Paris, France. He performed postdoctoral studies from Sidney Kimmel Cancer center/Sanford-Burnham Medical Research Institute (CA, USA), Julius-Maximilian Universitaet ? School of Medicine of Wuerzburg (Bavaria, Germany) and UNICAMP ?School of Medicine (So Paulo, Brazil). He is the director of Fluorotronics USA, Inc., a premier Fluoro-Spectroscopy service organization. He is also the Founder, President and CEO of Consulting, Global Innovation & Trade, Ltd., an emerging Brazilian company which offers a number of green and healthy solutions. He is a renowned inter- and multi-disciplinar Professional.

Google Scholar citation report
Citations: 289

Journal of Bioengineering & Biomedical Science received 289 citations as per Google Scholar report

Journal of Bioengineering & Biomedical Science peer review process verified at publons

Indexed In

arrow_upward arrow_upward